• Home
  • About Us
  • Contact
  • Subscribe
  • Your Account
  • Login
No Result
View All Result
Monday, May 29, 2023
Alternatives Watch
  • Home
  • Hedge Funds
    • Manager News
    • Mandates
    • Service Provider News
    • CTAs/Managed Futures
  • Private Equity
    • Manager News
    • Mandates
    • Service Provider News
  • Private Credit
    • Manager News
    • Mandates
    • Service Provider News
  • RE/Infrastructure
    • Manager News
    • Mandates
    • Service Provider News
  • Investor News
    • Endowments and Foundations
    • ESG
    • Pensions
    • Platforms
    • Consultants
  • Research
    • Investor Scorecard
    • Manager Scorecard
  • Subscribe
  • Home
  • Hedge Funds
    • Manager News
    • Mandates
    • Service Provider News
    • CTAs/Managed Futures
  • Private Equity
    • Manager News
    • Mandates
    • Service Provider News
  • Private Credit
    • Manager News
    • Mandates
    • Service Provider News
  • RE/Infrastructure
    • Manager News
    • Mandates
    • Service Provider News
  • Investor News
    • Endowments and Foundations
    • ESG
    • Pensions
    • Platforms
    • Consultants
  • Research
    • Investor Scorecard
    • Manager Scorecard
  • Subscribe
No Result
View All Result
Alternatives Watch
No Result
View All Result

BioMed Realty makes big entrance into Boulder market

Alternatives WatchbyAlternatives Watch
April 5, 2022
in Manager News, Real Estate/Infrastructure
BioMed Realty makes big entrance into Boulder market

Flatiron Park (artist rendering)

ShareTweetShareSendSend

BioMed Realty just gained a foothold in Colorado’s booming Boulder metropolitan area, and this was no small step: the Flatiron Park campus the Blackstone life sciences real estate portfolio company just acquired comprises no less than 1 million square feet of office and laboratory space across 22 buildings.

The seller was a joint venture of Crescent Real Estate, Goldman Sachs Asset Management’s Real Estate Business and Lionstone Investments. The value of the transaction was not disclosed, but Jon Bergschneider, president of West Coast markets at BioMed Realty, said the firm plans to invest an additional $200 million in redevelopment costs at the site.

Flatiron Park is already 90% leased to a mix of industry-leading technology and life science firms, and Boulder’s status as a regional tech and life sciences hub means there are more potential tenants around. BioMed Realty aims to become an active part of this community, including by contributing to the University of Colorado at Boulder’s BioFrontiers Institute, where researchers in the life sciences, physical sciences, computer science and engineering fields collaborate with industry partners to develop innovative solutions that enhance human health.

“Boulder has always been a market to watch, driven by highly educated talent, robust capital flow, an existing base of life science and tech pioneers and great quality of life,” said Mike Ruhl, vice president of Leasing at BioMed Realty. “As demand for office and lab space in the region continues to grow, we believe BioMed’s integrated platform and expertise is uniquely suited to support companies as they continue to scale in this key market.”

BioMed Realty owns and operates more than 13.7 million square feet of lab, technology and office real estate across seven major markets in the U.S. and the UK, including the Boston/Cambridge area in Massachusetts and Cambridge, UK.

Tags: BioMed RealtyBlackstoneLife Sciences
ShareTweetShareSendSend
Previous Post

Thoma Bravo closes second credit fund at $3.3bn

Next Post

Oaktree forms JV for real estate lending

Related Posts

People moves for week of May 26
Hedge Funds

People moves for week of May 26

CPP allocates nearly $6bn to 2023 private equity vintage
Pensions

CPP allocates nearly $6bn to 2023 private equity vintage

Harrison Street partners for student housing
Real Estate/Infrastructure

Harrison Street partners for student housing

KKR appoints first KREST CIO
Manager News

KKR appoints first KREST CIO

Alaska fund targets $2.6bn in private market deployment
Pensions

Alaska fund targets $2.6bn in private market deployment

Next Post
Oaktree forms JV for real estate lending

Oaktree forms JV for real estate lending

Log In/Out

Lost your password?

Search the AW Archives

No Result
View All Result

Recent News

People moves for week of May 26

People moves for week of May 26

Chatham sounds warning on RYAM debt maturities

Chatham sounds warning on RYAM debt maturities

Godspeed raises $250m for second investment program

Godspeed raises $250m for second investment program

CPP allocates nearly $6bn to 2023 private equity vintage

CPP allocates nearly $6bn to 2023 private equity vintage

Be an Alts Insider

Sign up for your FREE daily alts news briefing

Subscribe

Subscribe to AW
Alternatives Watch

© 2019-2022, All Rights Reserved  |  BMV Digital

Navigate Site

  • Investor News
  • Private Equity
  • Private Credit
  • Hedge Funds
  • Real Estate/Infrastructure
  • Subscribe
  • Your Membership
  • Terms of Service
  • Privacy Policy

Follow Us

No Result
View All Result
  • Home
  • Hedge Funds
    • Manager News
    • Mandates
    • Service Provider News
    • CTAs/Managed Futures
  • Private Equity
    • Manager News
    • Mandates
    • Service Provider News
  • Private Credit
    • Manager News
    • Mandates
    • Service Provider News
  • RE/Infrastructure
    • Manager News
    • Mandates
    • Service Provider News
  • Investor News
    • Endowments and Foundations
    • ESG
    • Pensions
    • Platforms
    • Consultants
  • Research
    • Investor Scorecard
    • Manager Scorecard
  • Subscribe

© 2019-2022, All Rights Reserved  |  BMV Digital

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Be an alts insider

Start your days in the know with our free newsletter

No, I don't want to be an alts insider

Thank

You!

Follow us
on LinkedIn

Lost your password?

This Website Uses Cookies
We use cookies on our website to provide necessary functions. By clicking “Accept”, you consent to the use of all strictly necessary cookies.
Do not sell my personal information.
Cookie Settings Accept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Save & Accept
Powered by CookieYes Logo